N-Zyme Biomedical (Series A)
Funding Details
Company Info
Company Description
N-Zyme Biomedical is focused on advancing its Phase 2 clinical programs and developing a novel pepsin inhibitor platform for reflux disease.
N-Zyme Biomedical is focused on advancing its Phase 2 clinical programs and developing a novel pepsin inhibitor platform for reflux disease.